CFDE Data Portal | Search LINC02097

	Label	Description
	LINC02097 Gene (Entity type)	ENSG00000226101 - long intergenic non-protein coding RNA 2097
	GSE173483 nutlin-3 U2OS 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173201 cisplatin 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 6 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 3 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE261563 CX-5461 9 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE146687 irinotecan 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Muscle 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Muscle 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Kidney 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx

LINC02097

ENSG00000226101 - long intergenic non-protein coding RNA 2097

GSE173483 nutlin-3 U2OS 3 v 0 human dn

A Gene Set from LINCS

GSE173201 cisplatin 2 v 3 human up

A Gene Set from LINCS

GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 6 v 4 human dn

A Gene Set from LINCS

GSE119369 H10 inhibition 3 v 5 human dn

A Gene Set from LINCS

GSE261563 CX-5461 9 v 4 human up

A Gene Set from LINCS

GSE146687 irinotecan 2 v 3 human dn

A Gene Set from LINCS

GTEx Muscle 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Muscle 20-29 vs 50-59 Up

A Gene Set from GTEx

GTEx Kidney 20-29 vs 50-59 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.